Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases

BACKGROUND: Pemetrexed and gemcitabine are both antimetabolites drugs approved in advanced non-small cell lung cancer (NSCLC). Their toxicity profile is well known. However, rare vascular side effects can occur such as vascular acrosyndromes and especially digital ischemia. The cause of this disfigu...

Descripción completa

Detalles Bibliográficos
Autores principales: Geier, Margaux, Babey, Hélène, Monceau-Baroux, Lucie, Quéré, Gilles, Descourt, Renaud, Cornec, Divi, Robinet, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047622/
https://www.ncbi.nlm.nih.gov/pubmed/33869037
http://dx.doi.org/10.3389/fonc.2021.644282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047622/
https://www.ncbi.nlm.nih.gov/pubmed/33869037
http://dx.doi.org/10.3389/fonc.2021.644282

Ejemplares similares